Celentyx Signs Drug Reprofiling Agreement With Meiji Seika Kaisha
Published: 24-Aug-2009
To seek alternative development paths for Meiji drug candidates using an application of the Immuno-Profiling platform - Novel Clinical Indication Profiling
Celentyx has entered into a drug reprofiling agreement with Meiji Seika Kaisha to seek alternative development paths for Meiji drug candidates, using an application of the Immuno-Profiling platform - Novel Clinical Indication Profiling (NCIP).
Celentyx’s NCIP identifies new uses for safe drugs to treat human immune system diseases e.g. inflammation, haematological cancers (leukaemias and lymphomas), allergy, autoimmune disease and graft rejection.
Nicholas Barnes, CEO of Celentyx, said: We are particularly pleased to add Meiji as a partner since they have a number of candidate drugs impacting a target that we have identified on key cell subsets within the human immune system. Celentyx’s NCIP provides an evaluation of a drug’s ability to signal responses in human immune cells with resolution to determine the therapeutic potential of small molecules and biologicals. Our goal is to provide partners with substantial value and revive development paths for drugs that retain potential for immune system disorders.
Delicious
Digg
Reddit
Stumble
Facebook
LinkedInNetwork Sites
Mail sent successfully
Suppliers To This Sector
Browse A-Z
World Courier
Offering Fully-Integrated GxP-Compliant Global Transport and Storage for the Pharmaceutical Industry...
WebWise Learning
Turning Information into Working Knowledge ...
Vetter Pharma International
High-Quality Aseptically Pre-Filled Injection Systems, Cartridges and Vials ...
Valsynthese
Hazardous Chemistry in Safe Hands ...
USB
Products from Affymetrix ...
Umicore Precious Metals Chemistry
Chemicals and Catalysts for Industrial Applications ...
White Papers
Browse A-Z
Your IP at Risk in Collaborations!
Free white paper: Ten steps to protect your R&D investment within partnerships. ...
Why, When and How to Conduct 14C Human Studies
Several risk-based strategies to assess metabolites exist. Whatever the strategy chosen, t ...
Why CAPA Still Matters
This free white paper explores the needs and effectiveness of correct CAPA control, how to ...
Water Treatment
From the control room to the downstream processing area and with an eye on utilities servi ...
Using the Mean Kinetic Temperature (MKT) As a Parameter to Determine Whether Perishable Goods Have Been Transported and Stored Correctly
Tecnosoft systems use MKT calculation to control the acquired values and report the user w ...
USB HotStart-IT for Real Time PCR
USB® Products from Affymetrix have a long-standing reputation in the life science marketpl ...
